Liquid valine and isoleucine for children with MSUD
Part of Brain & nervous system, Genetic & congenital, Hormones & metabolism clinical trials.
This study tests a new liquid form of two key supplements (valine and isoleucine) for children with maple syrup urine disease (MSUD). It aims to make it easier to take these supplements, which help manage the condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 1 and 16 years old.
- You have been diagnosed with maple syrup urine disease (MSUD).
- You already take valine and isoleucine supplements and are willing to take a new liquid version for 56 days.
- You do not have any other major health conditions.
- You follow your MSUD diet and supplement plan regularly.
- You understand what the study involves and can give permission (or a parent/caregiver can).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether new protein substitute tablets are acceptable for people with certain rare metabolic disorders. Participants will replace their usual protein substitute with the study tablets for 7 days to see if they can tolerate them.
This trial studies whether an oral treatment called MS-20 can improve ulcerative colitis (UC) in adults with moderate to severe disease. You may be asked to provide stool samples from home and avoid certain foods and medicines before screening and during the study.
This Phase 2 trial tests whether adding D-galactose can help people with a confirmed SLC35A2 genetic condition. It aims to improve symptoms such as seizures and ongoing stomach problems like vomiting or diarrhea.
This study is testing a new nutritional drink or powder to see if children like it, tolerate it well, and can stick with it. It replaces your child's current supplement with a new one, and researchers will check how it affects their digestion and overall health.
This trial tests whether an oral medicine (eluxadoline) can help children and teens with IBS-D, a condition that causes stomach pain and frequent loose stools. It’s a Phase 3 study, meaning it’s designed to confirm benefits and safety.
This trial compares a new treatment (tividenofusp alfa) to the current standard treatment (idursulfase) in children and young adults with MPS II. It’s looking to see which option works better and is safe, especially based on age and whether the disease affects the brain.
Hear when a new Maple Syrup Urine Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.